MedTrace Logo

SCUBE-1 and VAP-1 Levels on Diagnosis Pulmonary Embolism

NCT06733961 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-12-13

No results posted yet for this study

Summary

Acute pulmonary thromboembolism is a life-threatening disease. Clinical suspicion is essential for diagnosis because of lack of a specific finding for diagnosis of PTE. The aim of this study is to investigate the relationship between the diagnosis and prognosis of alternative biomarkers such as SCUBE-1 and VAP-1 in the diagnosis of clinically suspected acute PTE.

Patients who were admitted to the Emergency Department and diagnosed as acute PTE were included in the study. Patients with acute ischemic disease, liver failure, renal failure, pregnancy, active malignancy and/or history of known PTE were excluded from the study. A control group was formed from healthy volunteers at similar age and sex. SCUBE-1 and VAP-1 levels were studied from serum samples taken from the patient and control groups. Data were analyzed using by IBM SPSS V23.

Conditions

  • Pulmonary Embolism Acute

Interventions

DIAGNOSTIC_TEST

SCUBE-1 and VAP-1

There is no other study comparing these biomarkers with healthy volunteers in the diagnosis of pulmonary embolism.

Sponsors & Collaborators

  • Giresun University

    lead OTHER

Principal Investigators

  • Hizir U. Akdemir, Prof. · Ondokuz Mayıs University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06733961 on ClinicalTrials.gov